NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Appointment of HIQA CEO delayed

By Paul Mulholland - 21st Feb 2022

HIQA’s former CEO Mr Phelim Quinn, who retired at the end of 2021, has agreed to work part-time with the Authority for a number of months due to a delay in finalising the contract for a successor, the Medical Independent (MI) can report. 

A spokesperson told MI that a candidate for the position has been identified and an announcement will be made shortly. 

It had been hoped that a new CEO would already be in place; however, this was not possible due to a “slight delay” in finalising the contract, the spokesperson stated. 

The consequences of the delay in appointing Mr Quinn’s replacement were discussed at HIQA’s board meeting in December. 

“Due to the delay in the sanction for the post of the CEO, the timely appointment of a new CEO was impacted with the consequence that there is no overlap with the new CEO to ensure the transfer of organisational knowledge,” according to the minutes. 

It was proposed that Mr Quinn be retained for 1.5 days per week for a six-month period. 

Mr Quinn will begin this work when the new CEO takes up post, according to the spokesperson. 

Since Mr Quinn’s retirement, HIQA’s Deputy CEO and Director of Health Technology Assessment, Dr Máirín Ryan, has taken on the role of interim CEO. 

The Authority’s CEO “transition project” will also include the provision of coaching to two new executive directors to support the further development of those directorates. 

The new executive directors are Ms Carol Grogan, Chief Inspector; and Mr Sean Egan, Director of Healthcare, both of whom were appointed at the end of 2021. 

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read